RU2017108985A3 - - Google Patents

Download PDF

Info

Publication number
RU2017108985A3
RU2017108985A3 RU2017108985A RU2017108985A RU2017108985A3 RU 2017108985 A3 RU2017108985 A3 RU 2017108985A3 RU 2017108985 A RU2017108985 A RU 2017108985A RU 2017108985 A RU2017108985 A RU 2017108985A RU 2017108985 A3 RU2017108985 A3 RU 2017108985A3
Authority
RU
Russia
Application number
RU2017108985A
Other languages
Russian (ru)
Other versions
RU2788450C2 (ru
RU2017108985A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2017108985A publication Critical patent/RU2017108985A/ru
Publication of RU2017108985A3 publication Critical patent/RU2017108985A3/ru
Application granted granted Critical
Publication of RU2788450C2 publication Critical patent/RU2788450C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2017108985A 2010-01-11 2011-01-10 Способы проведения терапии потери веса у пациентов с доминирующей депрессией RU2788450C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29384410P 2010-01-11 2010-01-11
US61/293,844 2010-01-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2012128109A Division RU2616496C2 (ru) 2010-01-11 2011-01-10 Способы проведения терапии потери веса у пациентов с доминирующей депрессией (варианты)

Publications (3)

Publication Number Publication Date
RU2017108985A RU2017108985A (ru) 2019-01-22
RU2017108985A3 true RU2017108985A3 (enExample) 2020-06-26
RU2788450C2 RU2788450C2 (ru) 2023-01-19

Family

ID=

Also Published As

Publication number Publication date
US11033543B2 (en) 2021-06-15
US20190290640A1 (en) 2019-09-26
EP3659604A1 (en) 2020-06-03
EP2523557A4 (en) 2014-04-30
JP2013516493A (ja) 2013-05-13
IL248319B (en) 2020-06-30
US20110172260A1 (en) 2011-07-14
MX2012007898A (es) 2012-08-01
KR101841442B1 (ko) 2018-03-23
RU2616496C2 (ru) 2017-04-17
EP2523557B1 (en) 2019-09-25
AU2011203867B2 (en) 2015-12-03
IL248319A0 (en) 2016-11-30
JP2016138142A (ja) 2016-08-04
US20160143903A1 (en) 2016-05-26
US10322121B2 (en) 2019-06-18
MX383154B (es) 2025-03-13
EP2523557A1 (en) 2012-11-21
JP6196041B2 (ja) 2017-09-13
IL220610A0 (en) 2012-08-30
CA2785822C (en) 2019-06-25
US20210299119A1 (en) 2021-09-30
CA2785822A1 (en) 2011-07-14
RU2012128109A (ru) 2014-02-20
BR112012016783A2 (pt) 2015-09-01
AU2016201325B2 (en) 2017-12-21
MX344303B (es) 2016-12-13
ES2762113T3 (es) 2020-05-22
WO2011085331A1 (en) 2011-07-14
KR20120124423A (ko) 2012-11-13
RU2017108985A (ru) 2019-01-22
AU2011203867A1 (en) 2012-07-19
US9248123B2 (en) 2016-02-02
CN102724878A (zh) 2012-10-10
IL220610A (en) 2016-10-31
AU2016201325A1 (en) 2016-03-17
KR20170121333A (ko) 2017-11-01

Similar Documents

Publication Publication Date Title
BR112012030039A2 (enExample)
BR112012028408A2 (enExample)
BR112012029986A2 (enExample)
BR112012027808A2 (enExample)
BR112012024897A2 (enExample)
BR112012026492A2 (enExample)
BR112012031500A2 (enExample)
BR112012025307A2 (enExample)
BR112012002126A2 (enExample)
BR112012026946A2 (enExample)
BR112012025482A2 (enExample)
BR112012031826A2 (enExample)
BR112012025577A2 (enExample)
BR112012023249A2 (enExample)
BR112012028186A2 (enExample)
BR112012027015A2 (enExample)
BR112012026403A2 (enExample)
BR112012027945A2 (enExample)
BR112012024872A2 (enExample)
BR112013003284A2 (enExample)
BR112013002646A2 (enExample)
BR112012022788A2 (enExample)
BR112012016895A2 (enExample)
BR112012028859A2 (enExample)
BR112012029562A2 (enExample)